Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 9Phase 1 7Phase 2/3 4Phase 1/2 2Phase NA 1

Status

Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 40Methods 37Exercise 36Educational Status 36Practice Guidelines as Topic 35Surveys and Questionnaires 33Early Intervention, Educational 32Radiotherapy 25Radiosurgery 25Magnetic Resonance Spectroscopy 23Interviews as Topic 21Blood Specimen Collection 17Surgical Procedures, Operative 14Radiotherapy, Intensity-Modulated 12Palliative Care 12Counseling 12Radiation 11Nutrition Assessment 11Specimen Handling 10Resistance Training 10Proton Therapy 8Mammography 8Biopsy 8Radiofrequency Ablation 7Exercise Test 7Drug Therapy 7Diet Therapy 7Control Groups 7Yoga 6X-Rays 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡